This test is designed to detect genetic mutations in the HBB gene responsible for Beta Thalassemia, a hereditary blood disorder characterized by reduced or absent synthesis of the beta-globin chains of hemoglobin. The prenatal diagnosis is performed on fetal DNA obtained through procedures such as chorionic villus sampling (CVS) or amniocentesis, allowing early identification of affected fetuses.